共 50 条
- [1] A 52 weeks dupilumab treatment for moderate to severe atopic dermatitis in Korea: long-term efficacy and safety in real world [J]. Scientific Reports, 11
- [9] Efficacy and safety of dupilumab in pediatric patients with moderate to severe atopic dermatitis: a real-world study [J]. Archives of Dermatological Research, 2023, 315 : 467 - 472
- [10] Efficacy of dupilumab in real practice in the treatment of severe forms of asthma and atopic dermatitis (comparative retrospective study) [J]. TERAPEVTICHESKII ARKHIV, 2023, 95 (07): : 568 - 573